期刊文献+

荧光原位杂交检测尿脱落细胞染色体异常对膀胱肿瘤诊断的意义 被引量:3

下载PDF
导出
摘要 目的探讨尿脱落细胞荧光原位杂交检测染色体异常在诊断膀胱肿瘤中的临床意义。方法收集我院经治的35例膀胱肿瘤患者(试验组)和30例在我院进行健康体检的正常人(对照组)的尿液,采用3、7、17号染色体着丝粒探针进行荧光原位杂交,并观察两组对象细胞染色体畸变情况。结果膀胱肿瘤患者的3、7、17号染色体畸变数与正常人的染色体均有显著性差异(P<0.05)。3、7、17三种探针的阳性率分别为31.43%、45.71%、40.00%,而联合三种探针的阳性率为62.86%,与单独一种探针比较均具有显著性差异(P<0.05)。结论荧光原位杂交检测尿脱落细胞染色体异常可以作为膀胱肿瘤诊断的一项常规检查方法,无创、快速、有效,值得在临床推广应用。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2011年第13期2432-2433,共2页 Chinese Journal of Gerontology
  • 相关文献

参考文献8

二级参考文献67

  • 1乔忠杰,王国民.膀胱癌复发与染色体畸变关系的研究进展[J].国外医学(泌尿系统分册),2005,25(2):167-170. 被引量:5
  • 2Degtyar P, Neulander E, Zirkin H, et al. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. Urology, 2004, 63 : 398-401.
  • 3Tsukamoto M, Matsuyama H, Obaket, et al. Numerical aberration of chromosome 9 in bladder cancer: a possible prognostic marker for early tumor recurrence. Cancer Genet Cytogenet, 2002, 134: 41-45.
  • 4Hoglund M, Sail T, Heim S, et al. Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma. Cancer Res, 2001, 61:8241-8246.
  • 5Zhang J, Zheng S, Gao Y, et al. A partial allelotyping of urothelial carcinoma of bladder in the Chinese. Carcinogenesis, 2004, 25 : 343-347.
  • 6Sarosdy MF, Kahn PR, Ziffer MD, et al. Use of a muhitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria. J Urol, 2006, 176:44-47.
  • 7Kruger S, Mess F, Bohle A, et al. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder. Int J Oncol, 2003, 23:41-48.
  • 8Watters AD, Ballantyne SA, Going JJ, et al. Aneusomy of chromosomes 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder. BJU Int, 2000, 85:42-47.
  • 9Ribal MJ, Alcaraz A, Mengual I, et al. Chromosomal high- polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder. Eur Urol, 2004, 45:593-599.
  • 10Krause FS, Rauch A, Schrott KM, et al. Clinical decisions for treatment of different staged bladder cancer based on multitarget fluorescence in situ hybridization assays. World J Urol, 2006, 24 : 418-422.

共引文献22

同被引文献30

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部